A Pilot Survey on the Licensing of DNA Inventions

Journal of Law, Medicine and Ethics 31 (3):442-449 (2003)
  Copy   BIBTEX

Abstract

Intellectual property in biotechnology invention provides important incentives for research and development leading to advances in genetic tests and treatments. However, there have been numerous concerns raised regarding the negative effect patents on gene sequences and their practical applications may have on clinical research and the availability of new medical tests and procedures. One concern is that licensing policies attempting to capture for the benefit of the licensor valuable rights to downstream research results and products may increase the financial risks and cliniinish potential payoffs of — and therefore motivation for — performing downstream research and development. In addition, very broad patent claims allowed by the U.S. Patent and Trademark Office, the sheer growth in patents claiming genetic sequences, and threats of overlapping patents create a veritable minefield for researchers in both academia and industry. The concern is that research may be stifled because of the high cost and hassle of negotiating access.

Other Versions

No versions found

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 101,458

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

Analytics

Added to PP
2010-08-31

Downloads
84 (#250,014)

6 months
10 (#413,587)

Historical graph of downloads
How can I increase my downloads?

Author's Profile

Citations of this work

Livin' with the MTA.Philip Mirowski - 2008 - Minerva 46 (3):317-342.

Add more citations

References found in this work

Add more references